Vyome Holdings, Inc. (HIND)

2.205 0.00 (0.00%) USD  |  NASDAQ  |  Aug 28, 16:00
2.15 -0.06 (-2.49%) After-Hours: 20:00
More

Vyome Holdings Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for HIND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2025. Start Trial.
Date Value
May 19, 2026 --
March 25, 2026 --
Date Value
November 18, 2025 --
October 02, 2025 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Cardiac Biotech Solutions, Inc. --
Anika Therapeutics, Inc. Upgrade
Enovis Corp. Upgrade
Edwards Lifesciences Corp. Upgrade
Perspective Therapeutics, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade